Cardiff.jpg
Cardiff Oncology to Present at Upcoming Investor Conferences in May
13 mai 2024 16h05 HE | Cardiff Oncology, Inc.
SAN DIEGO, May 13, 2024 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of...